The pharmacy-benefit managers, or PBMs, have devised formularies of preferred medicines that encouraged use of higher-priced drugs over lower-priced alternatives, the Republican-led House Committee on Oversight and Accountability found. They promised to control costs, but have instead steered patients toward higher-priced medicines and affiliated pharmacies. #healthcare #HealthcareReform #HCR4US #OnePayerStates
https://www.wsj.com/health/pharma/drug-middlemen-push-patients-to-pricier-medicines-house-probe-finds-80c20fda